AlzDiscovery:使用蛋白质结构信息识别导致阿尔茨海默病的误解突变的计算工具
Qisheng Pan1,2, Georgina Becerra Parra1,2, Yoochan Myung1,2
1The Australian Centre for Ecogenomics, School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane, Australia.
Protein science : a publication of the Protein Society
|September 14, 2024
概括
这项研究引入了一种机器学习模型,用于识别阿尔茨海默病 (AD) 突变,改进AD查和个性化治疗. 该模型通过分析蛋白质结构和稳定性,准确地预测引起疾病的变体.
科学领域:
- 遗传学和生物信息学 遗传学和生物信息学
- 神经退行性疾病 神经退行性疾病
- 计算生物学 计算生物学
背景情况:
- 阿尔茨海默病 (AD) 是导致痴呆的主要原因,其特点是蛋白质聚合物.
- 与AD相关的蛋白质中的错误突变可以改变蛋白质功能并增加疾病风险.
- 现有的变体识别方法往往忽略了蛋白质3D结构中的突变的影响.
研究的目的:
- 开发一种机器学习模型来分类导致阿尔茨海默病的突变.
- 为了利用基于序列和结构的特征来改进变体预测.
- 为AD查和个性化治疗开发提供有价值的资源.
主要方法:
- 机器学习分析对21种与AD相关的蛋白质中的误解突变进行了分类.
- 利用计算工具来评估突变对蛋白质稳定性的影响.
- 开发了一个包含序列和结构特征的预测模型,并通过样本重量调整进行了优化.
主要成果:
- 在AD相关蛋白质内的致病突变中发现了对AD相关蛋白质中破坏稳定的影响的偏见.
- 实现了高性能:在盲测试中达到0.95 AUC,在临床验证中达到0.70 AUC,超过了最先进的方法.
- 特性解释强调了疏水环境和极性相互作用在突变致病性中的重要性.
结论:
- 开发的模型在预测AD引起误解突变方面提供了卓越的准确性.
- 该研究介绍了AlzDiscovery,这是一个用于预测AD相关蛋白质突变表型的Web服务器.
- 这些发现支持加强AD查和开发有针对性的个性化治疗方法.
更多相关视频
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
18.9K
06:50Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
1.8K
相关概念视频
Alzheimer's Disease: Overview
452
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
452
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
